Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore cutting-edge technologies transforming pancreatic ductal adenocarcinoma (PDAC) research through this comprehensive webinar featuring two leading researchers. Learn how Dr. Hartland Jackson utilizes integrated spatial proteomics and laser-capture mass spectrometry to map tumor, stroma, and immune interactions, uncovering novel molecular co-dependencies and enhancing patient stratification strategies. Discover how Dr. Max Reichert applies organoid models and spatial transcriptomics to reveal hierarchical cell states that drive PDAC's heterogeneity, metastatic potential, and therapy response mechanisms. Understand how spatial single-cell and multi-omics data outperform traditional genomic and clinical features in predicting patient outcomes, recognize that distinct tumor cell states exhibit variable metastatic potential and therapy sensitivity that can be dynamically reshaped by treatment, and learn how organoid-based models successfully recapitulate cellular heterogeneity and hierarchical organization in pancreatic cancer. Engage in live discussion and Q&A sessions with leading researchers to gain valuable insights for improving cancer diagnosis, guiding therapy decisions, and informing prevention strategies, with all sessions available on-demand for flexible continued learning and engagement.
